Atai Life Sciences N.V.
ATAI
$4.76
-$0.07-1.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -119.40M | -148.99M | -149.27M | -128.60M | -58.07M |
| Total Depreciation and Amortization | 751.00K | 606.00K | 473.00K | 349.00K | 340.00K |
| Total Amortization of Deferred Charges | 495.00K | 566.00K | 515.00K | 426.00K | 394.00K |
| Total Other Non-Cash Items | 43.58M | 76.03M | 75.04M | 50.25M | -22.70M |
| Change in Net Operating Assets | -997.00K | -5.92M | -9.20M | -2.53M | 844.00K |
| Cash from Operations | -75.57M | -77.71M | -82.44M | -80.10M | -79.19M |
| Capital Expenditure | -1.15M | -1.02M | -6.00K | -8.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 359.00K | 359.00K | 359.00K | 480.00K | 0.00 |
| Divestitures | -- | -- | -- | -443.00K | -443.00K |
| Other Investing Activities | 30.96M | 37.35M | 58.82M | 51.76M | -19.09M |
| Cash from Investing | 30.17M | 36.69M | 59.17M | 51.79M | -19.54M |
| Total Debt Issued | 5.00M | 5.00M | 5.00M | 5.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 80.00M | 60.70M | 535.00K | 400.00K | 345.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.59M | -725.00K | -161.00K | -8.64M | -8.48M |
| Cash from Financing | 72.41M | 64.98M | 5.37M | -3.24M | -8.14M |
| Foreign Exchange rate Adjustments | 598.00K | 458.00K | 362.00K | 27.00K | 108.00K |
| Miscellaneous Cash Flow Adjustments | -- | 1.00K | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 27.61M | 24.42M | -17.53M | -31.53M | -106.76M |